The Precedent: US pharmaceutical enforcement, PBM litigation and the RedFlag Index™

Full index →

Full methodology, company profiles and enforcement findings: PDF report available on the index page.

Download Report
Companies Tracked
10
Avg Score
62
Company-Matter Entries
54
Open Company-Matters
32
All reports →
  1. 340B Program

    Missouri orders Eli Lilly to drop 340B claims-data condition after hospital cut-off

  2. PBM Oversight

    House Oversight chair investigates whether PBMs used audits to punish pharmacies that backed reform

  3. False Claims Act

    DOJ and HHS open six-month window for healthcare companies to self-disclose False Claims Act violations

  4. Drug Pricing

    Pennsylvania sues the three largest insulin makers and PBMs over alleged pricing scheme